Tune in to find out:
- How Long-Acting Injectables (LAIs) have changed the landscape of psychiatric care
- Provider barriers to use of LAIs
- How an Integrative care model supports the expansion and use of LAIs
- LAIs and patient persistency
- And more.
About Advantage Healthcare Services (AHCS):
Advantage Healthcare Services is strategically positioned as one of California’s fastest growing independent pharmacy groups specializing in behavioral health.
AHCS has extensive experience serving patients with behavioral health needs through existing partnerships with approximately 250 clinics in California, serving approximately 200,000 behavioral health lives. Through partnerships, AHCS provides clinical pharmacy services and data analytics support.
AHCS’s consultative approach tailors solutions that address the unique needs of patients with complex health conditions and integrates seamlessly with the providers that serve them.
About Dr Rimal Bera, MD
Rimal Bera, MD is Clinical Professor of Psychiatry at the University of California, Irvine Department of Psychiatry. Dr. Bera earned a Bachelor of Science Degree in Biology from the University of California, Irvine, and a medical degree from the University of California, Irvine in 1987. He completed his psychiatry residency at the University of California, Irvine in 1991. He has been a Full Time Faculty at the University of California, Irvine since 1991. His primary area of specialty is adult psychiatry with a focus on schizophrenia, bipolar disorder, depression and memory disorders.
Dr. Bera is a distinguished fellow of the American Psychiatric Association. He serves as Medical Director for Universal Care Behavioral Health for California and as Medical Director at the John Henry Foundation in Santa Ana, a high-level center for the treatment of Schizophrenia. At the John Henry Foundation, 4th year psychiatry residents from the Department of Psychiatry at the University of California, Irvine receive state of the art clinical training. He formally was chairman of the Public Affairs Committee of the Orange County Psychiatric Society from 1991 to 2016. He was been on the Board of Directors of the Mental Health Association of Orange County from 1991 to 2012 and served as a past President of the Board. He is the Past President of the University of California, Irvine School of Medicine Alumni. In 2014 Dr. Bera was the recipient of the Orange County Medical Association Physician of the Year Award. He has regularly been chosen as a Physician of Excellence for orange County since 2012.
Dr. Bera has been a principal investigator and co-investigator in over 180 clinical trials over the last 30 years. Dr. Bera has lectured extensively in the United States, Canada, and Europe about the major mental illnesses and their latest treatments. More recently, over the past 7 years, his interest has evolved into health care policy, looking at models of care that combine high level care for both physical and mental disorders with an emphasis on health outcomes economic research. Today he works regularly with physicians of all specialties helping them incorporate mental health evaluations and treatments into their practices.
Brian Kobayashi, BS Chela Wright, MD, Michael Burns, MD, Rimal Bera, MD Ketamine for acute catatonia: A case report: Current Psychiatry June 2021 doi: 10.12788/cp.0132
Alex Wang BS1, Kishen Bera BS1, Ajay N. Sharma BS1, Bao-Nhan Nguyen MD1, Nathan W. Rojek MD, Rimal Bera MD. Nationwide Needs Assessment Survey for Financial Literacy Among Psychiatry Residents. Academic Psychiatry June 2021.
Aiyer, S. Hurria, A. Bera, R.: Understanding the Role of Peer Mentor Support for United States Medical Students. American Psychiatric Association Annual Meeting. May 2019. San Francisco, CA
Bera, R.B., Offord, S., Zubek, D., Lau, G., Lin, J., Baker, R., Karson, C.: Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiaition of treatment with long-acting injectable antipsychotics. Journal of Medical Economics, 2013:16; pp 522-528.
Bera, R.B., Potkin, S., Zubek, D., Lau, G.: Perspectives on Long-Acting Injectable Antipsychotics for Schizophrenia: Consideration of Patient Cultural/Racial Differences in Planning Individual Treatment. Journal of Clinical Psychiatry: June 2013
Lochhead, J., Nelson, M. Bera, RB. Modafinil associated with new onset obsessive-compulsive disorder. Annals of Clinical Psychiatry. February 2018.
Anders Waalen, Kevin Bera & Rimal Bera (2019): Suicide hotspots, interventions, and future areas of work at a California University, Death Studies,DOI:10.1080/07481187.2019.1595221
Shawyon A. Sedaghati; Rimal B. Bera; Jeff Baker. Grief Support: StatPearls [Internet]January 14, 2020.